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Abstrak
Latar belakang: Virus Polio Liar dapat menyebabkan kelumpuhan dan dapat dicegah dengan imunisasi. 
Untuk memonitor transmisi virus polio liar dilakukan surveilans Acute Flaccid Paralysis (AFP) dan investigasi 
laboratorium yang  telah dimulai sejak tahun 1995 di Indonesia. Virus polio liar Indigenous terakhir ditemukan 
di Indonesia tahun 1995. Indonesia masih memiliki ancaman importasi virus polio liar dari negara endemis 
dan mutasi virus polio dari vaksin yang menyebakan kelumpuhan yang sama seperti virus polio liar. Artikel ini 
bertujuan untuk memberikan gambaran mengenai surveilans AFP berbasis laboratorium di Indonesia pada 
tahun 2003-2013 sehingga mengantarkan Indonesia sebagai negara bebas polio pada tahun 2014. 
Metode: Data yang dianalisis adalah data kasus AFP seluruh Indonesia periode tahun 2003-2013. 
Data didapat dari laboratorium jejaring laboratorium Polio di Jakarta, Bandung, Surabaya dan Sub 
Direktorat Surveilans, Direktorat Surveilans dan Karantina Kesehatan, Direktorat Jenderal Pencegahan 
dan Pengendalian Penyakit. Data di analisis menggunakan program Microsoft Excel.
Hasil: Sebanyak 305 kasus AFP  yang disebabkan oleh infeksi virus polio liar tipe 1 impor ditemukan pada 
tahun 2005 dan 2006. Terdapat 39 kasus AFP yang disebabkan cVDPV tipe 1 ditemukan di Pulau Madura 
pada tahun 2005. Virus polio liar tipe 1 hanya ditemukan di pulau Sumatera dan Jawa. Penyebaran Virus 
polio berhasil dihentikan pada tahun 2006 dan sudah tidak ditemukan lagi hingga tahun 2013. 
Kesimpulan: Surveilans AFP berbasis laboratorium yang baik berhasil memantau dan mendeteksi sirkulasi virus 
polio. Peningkatan kinerja surveillance AFP diperlukan untuk membuktikan terhentinya transmisi virus polio 
sehingga eradikasi polio secara global dapat diraih. (Health Science Journal of Indonesia 2019;10(1):8-14) 
Kata kunci: surveilans, laboratorium polio, Acute Flaccid Paralysis 
Abstract
Background: Wild Poliovirus can cause flaccid paralysis and can be prevented by immunization. To monitor 
wild polio virus transmission, Acute Flaccid Paralysis (AFP) surveillance and laboratory investigations was 
initiated in 1995 in Indonesia. The last indigenous wild poliovirus found at 1995 in Indonesia. Indonesia still 
has the threat of imported wild polio viruses from endemic countries and poliovirus mutation from vaccine 
that can cause paralytic as well as wild poliovirus. The aim of this article is to describe the laboratory-based 
AFP surveillance in Indonesia from 2003-2013 so that it had led the Indonesia certified for polio free in 2014.  
Methods: Data analysis performed on AFP cases data from all provinces in Indonesia period of 2013-
2014. Data were collected from polio laboratories network in Jakarta, Bandung, Surabaya and the Sub 
Directorate of Surveillance, Directorate of Surveillance and Health Quarantine, Directorate General of 
Disease Prevention and Control. Data were analyzed using Microsoft Excel program. 
Results: 305 paralysis cases were caused by imported type 1 wild poliovirus infection were found in 2005 
and 2006. 39 paralysis cases caused by type 1 cVDPV infection were also found on Madura Island in 2005. 
Type 1 wild polioviruses only found on the Sumatra and Java island. The wild poliovirus transmission was 
stopped in 2006 and was no longer found until 2013. 
Conclusion: Good laboratory-based AFP surveillance has been successfully monitoring and detecting  the circulation 
of the poliovirus. Improved  AFP surveillance performance is needed to prove cessation of poliovirus transmission  
so that eradication of poliovirus can be achieved globally. (Health Science Journal of Indonesia 2019;10(1):8-14)
Keywords: surveillance, polio laboratory, Acute Flaccid Paralysis
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Poliovirus can cause poliomyelitis in humans, 
mainly affects children who have no immunity to 
the poliovirus. Poliomyelitis can be prevented by 
immunization which through Expanded Program on 
Immunization (EPI) started in 1988, the poliovirus 
transmission has been interrupted.  The number of 
poliomyelitis cases due to wild poliovirus reduced 
to more than 99%  in over 125 countries  globally 
with  only 3 endemic countries left nowadays; 
Afghanistan, Nigeria, and Pakistan. Wild poliovirus 
type 2 has not been found since 1999 globally while 
the last case of type 3 wild poliovirus reported in 
2012 in Nigeria. Global Polio eradication can be 
achieved if this condition can be maintained.1-6
World Health Organization has implemented four 
strategies since the eradication program began in 
1988, including strategy to increase immunization 
coverage as well as  acute flaccid paralysis (AFP) 
surveillance and laboratory investigations. The 
AFP surveillance and laboratory investigation play 
an important role to ensure the cessation of wild 
poliovirus transmission. As paralysis was  only 
shown in 0.1- 1% of children infected with the 
poliovirus,  acute flaccid paralysis (AFP) surveillance 
followed by confirmation with virological labo-
ratory  examination needed to assure that  there 
is no paralytic cases caused by poliovirus. AFP 
surveillance activities which including laboratory 
confirmation activities were carried out on children 
under 15 years old through surveillance officers at 
the District and Provinces Health Service Offices. In 
Indonesia, this programme have been implemented 
in Indonesia since 1995.7-9 
In Indonesia, indigenous wild poliovirus circulation 
has not been found any more after 1995. However, 
Indonesia still faces threat of the wild poliovirus 
importation from polio-endemic countries as the 
last previous outbreak in 2005. Moreover polio 
immunization program  in Indonesia utilize  Oral 
Polio Vaccine containing live attenuated vaccines 
which might become  another threat because the 
vaccine polio virus may experience mutations in 
the human body (Vaccine Derived Polio Virus/
VDPV) and cause symptoms such as wild polio virus 
infections.1,7,10
The sensitive and active surveillance in finding 
AFP cases and laboratory quality is crucial role 
in ensuring that poliovirus transmission has been 
interrupted and immunization programme has 
worked. Documentation of the cessation of the 
poliovirus transmission is needed in the certification 
of polio eradication globally. The data collected may 
provide evidence of the elimination of the poliovirus 
and can also be used as a guideline in making plans 
to prevent and eradicate polio infections. This study 
provides epidemiological and virological information 
on AFP cases in Indonesia  from 2003-2013 which 
further gives an overview of polio eradication 
program  in Indonesia before the certification of 
polio free is obtained.  Furthermore, through the data 
obtained during the period 2003 – 2013,  it can be 
seen the development of the surveillance system in 
Indonesia in detecting the circulation of wild polio 
viruses in Indonesia as experiences and  a lesson 
learnt of laboratory networking to prevent poliovirus 
transmission and achieving polio-free certification 
including response to the poliovirus outbreak. 
METHODS
Study Design
Indonesia has 34 provinces which spread over 5 
major islands and thousands of small islands. The 
health system is managed by the central government 
in collaboration with local governments with tiered 
tasks and responsibilities given. This article analyzes 
AFP surveillance data reported and sent by specimens 
to the polio laboratory network for the period 2003-
2013 before Indonesia was declared polio-free by the 
World Health Organization. Data analysis covered 
surveillance activities in finding AFP cases, retrieval 
and condition of stool specimens.
Acute Flaccyd Paralysis surveillance activity
AFP surveillance implements hospital-based 
and community-based surveillance systems in 
finding AFP cases. AFP surveillance in Indonesia 
was performed by Vaccine Preventable Diseases 
surveillance department Directorate General of 
Center for Disease Prevention and Control (CDPC) 
involved all relevant health workers in health 
facilities to actively find and report acute paralysis 
cases found in hospitals and health centers and also 
involved other leaders in the community to capture 
cases in communities. Specimens should be collected 
from the AFP cases with at least 2 stool specimens are 
obtained in 24 hours apart within 14 days after onset 
and then  sent to laboratory accredited by WHO. The 
specimens should be received in a laboratory with 
good condition. Acute Flaccid Paralysis surveillance 
officers in districts will send reports to CDPC 
Indonesia every month. 
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Laboratory Investigation
The collected specimens were sent to three polio 
network laboratories, namely the Center for 
Biomedical and Basic Health Technology, National 
Institute of Health Research and Development 
Laboratory in Jakarta which examined samples 
from the all the provinces in Sumatera Island region, 
Kalimantan Island region, Banten Province and DKI 
Jakarta Province; Biofarma Laboratory in Bandung 
which examined samples from West Java Province, 
Central Java Province and D.I.Yogyakarta Province 
and; Balai Besar Laboratorium Kesehatan (BBLK) 
Surabaya Laboratory which examined specimens 
from Sulawesi Island, East Java, Bali, Nusa Tenggara, 
Moluccas, and Papua Island region. The specimens 
were examined in the laboratories using procedures 
established by WHO and results were reported to 
the Expanded Program on Immunization data in Sub 
Directorate Surveillance, Directorat Surveillance 
and Health Quarantine, DG CDPC as well as to the 
provincial health offices.9 
Data Analysis
The data from AFP cases were analyzed combining 
laboratories and epidemiology data from CDPC 
which collected between 2003-2013. The data which 
used in this study is analysed with microsoft excel 
programme including year, number of AFP cases, 




The AFP cases were found by surveillance officers 
and reported to CDPC and followed by specimens 
collection and sent them to the polio laboratory 
network according to their  coverage working area. 
Figure 1 shows the number of AFP cases reported 
and specimens collected and sent to the laboratory. 
The AFP cases reported in 2003 and 2004 were still 
relatively few, which then begun to increase in 2005, 
almost reaching twice number of case discoveries in 
the previous year. The number of cases since 2005 
was then relatively consistent until 2013. From the 
figure it was also seen that less than 10% of cases were 
reported without specimens sent to the laboratory. 
Table 1 shows AFP surveillance performance with 
the number of specimens received in the laboratory 
and the condition of the specimen. It appears that 
specimens in adequate conditions range from 78-
90% of all cases found and reported to central 
surveillance. Table 1 also illustrates the increase in 
Non Polio AFP rates. Non-polio AFP rate is really 
the incidence of AFP caused by diseases other than 
poliomyelitis. Before 2005 there were still around 
1/100,000 population of children, whereas in 2005 to 
2013 Non Polio AFP Rate increased to >2/100,000 
population of children.
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Table 1. AFP Surveillance Performance Based on Adequate Specimens and Non Polio AFP Rate
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The laboratory tests are virus  culture by inoculating 
specimens to both RD and L20B cell lines followed 
by  identification of Poliovirus using the Probe and 
Hibridization (2003-2008) and Polymerase Chain 
Reaction method (since 2009). Table 2 describes 
the results of viral culture and identification of polio 
virus in stool specimens from AFP cases. The wild 
poliovirus were found in Indonesia  both in 2005 and 
2006. The Vaccine Derived Poliovirus (VDPV) type 
also detected in 2005 while vaccine Poliovirus were 
detected every year with the highest was in 2005. 
VDPV was originated from vaccine poliovirus and 
mutated during over time.10 Vaccine poliovirus type 
3 was the most frequently detected amongst the 
others.  
In 2005, there was an outbreak of wild poliovirus 
in Indonesia. First case of wild poliovirus found in 
Cidahu district, West Java province in March 2005, 
which then spread to eight other provinces in Java 
and Sumatera. Distribution of wild type 1 polio cases 
in Indonesia in 2005-2006 was shown in figure 2.
Table 2. Laboratory Result of AFP Specimens
Year Number of Specimen
Vaccine Poliovirus  Wild Poliovirus  VDPV
P1 P2 P3  P1 P2 P3  P1 P2 P3
2003 737 1 1 3  0 0 0  0 0 0
2004 779 0 0 1  0 0 0  0 0 0
2005 1900 41 42 58  303 0 0  39 0 0
2006 1497 24 9 13  2 0 0  0 0 0
2007 1516 7 5 9  0 0 0  0 0 0
 2008 1641 6 8 4  0 0 0  0 0 0
2009 1685 3 3 5  0 0 0  0 0 0
2010 1601 4 2 6  0 0 0  0 0 0
2011 1692 5 6 20  0 0 0  0 0 0
2012 1922 4 6 11  0 0 0  0 0 0
2013 1922 0 6 9  0 0 0  0 0 0
Figure 2. Mapping of Wild Poliovirus Cases in Indonesia in 2005-2006
DISCUSSION
This paper discusses laboratory-based AFP sur-
veillance activities in Indonesia for the period 
2003 - 2013 that represent the period before the 
discovery of paralysis cases due to imported wild 
polio virus infection in 2005 until Indonesian polio-
free certification was achieved in 2014. AFP cases 
reported in 2003-2004 were less than the number of 
cases in the previous year. The highest number of 
AFP cases was reported in 2005 due to an outbreak 
of imported type 1 poliovirus which was first 
discovered on Cidahu, Sukabumi, West Java. The 
increased number of  AFP cases detected which  more 
than two times from the previous year was due to 
avoid a paralytic case that escaped from monitoring. 
All cases of acute paralysis including paralysis 
of more than 2 months were investigated and 
reported, followed by collection of stool specimens 
to expand the possibility of finding paralytic cases 
due to poliovirus. This strategy was followed with 
the increase of cases with inadequate specimens in 
2005-2006. The number of case findings after 2005 
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was constant until 2013 may due to an increase in 
non-Polio AFP rates that followed the rules for 
finding cases in endemic areas. An increase in cases 
is needed to prove that there are no more paralyzed 
cases caused by wild poliovirus as evidenced by the 
results of laboratory tests. 9,13-16
As shown in figure 1 and table 1, not all reported 
and investigated AFP cases had specimens. There are 
several reasons of the incompleteness AFP such as 
the AFP case location was difficult to reach by the 
health officers (far geographically difficult and lack 
of transportation), the difficulties of AFP patients 
for defection. The otherreason of incomplete AFP 
investigation was because the AFP cases detected 
after 2 months of paralysis symptoms onset, which 
made the collection of specimens no longer needed. 
In addition to incomplete specimens collection, 
more than 65% of the specimens categorized as 
non-adequate. Inadequate specimens can be caused 
by specimens collection more than 14 days from 
paralysis,  specimens were not collected, or just 
collecting and sending one specimen, and the 
condition of the specimens at arrival in the laboratory 
were  not adequate. Adequate specimens must be 
above 80% in every single year and this condition 
cannot be achieved in 2005 and 2006.8 The delay in 
the collection of the AFP specimens might be due to 
the delays in case finding. The poliovirus was still 
excreted in 66% -100% in 2 weeks after the onset 
and the viruses excretion decreases to 15% at the 
fifth and sixth weeks. Stool can still be collected until 
the eighth week to catch the possibility of the virus 
still being excreted. WHO does not recommend to 
collect AFP specimens after 2 months of paralysis, 
although the research was conducted in children in 
China found that the poliovirus was still detected  in 
the stool from AFP cases after the twelfth week.11-12  
Inadequacy of the specimens was also due to 
collection of only one specimens instead of two. 
Collecting a pair of specimens is very important 
because if only 65% of AFP cases showed positive 
poliovirus detection in both stools, the sensitivity 
of the poliovirus was reduced in 7% of AFP cases.17 
In addition, around 15% of the specimens which 
sent to the laboratory were received inappropriate 
conditions that were not cold or insufficient volume. 
The main causes of this problem were because the not 
enough ice packs, the ice pack is not replaced when 
melted before reach the laboratory. The specimens 
temperature affects the stability of the virus. The high 
temperature for a long period causes the viral titre 
decreases,and will affect the results of laboratory 
tests. The poliovirus is stable for 72 hours at 2-8oC 
until they arrive at the laboratory. Type 1 poliovirus 
is most affected by increasing temperature. Virus 
titre decreased by 20% if stored at 22oC for 14 days 
and 50% if stored at 36oC for 14 days.18
The risk of occurrence of AFP cases due to 
importation of poliovirus is very high. Global data 
for the period of 2003-2014 showed the spread 
of wild poliovirus cases because of the imported 
polioviruses were very significant of 53% in 2005, 
85% in 2010 and 62% in 2013.20-22 
The AFP surveillance system has successfully 
monitored the wild poliovirus circulation with a 
finding of 305 cases of AFP caused by type 1 wild 
polio virus infections in Indonesia in 2005.19  This 
poliovirus originated from an African country which 
transmitted through Indonesian citizens who visit 
the Middle East.9 The poliovirus was first detected 
in Cidahu West Java and then spread to Banten 
and quickly spread to the some provinces in Java 
and Sumatra Island. The immunization response to 
epidemics through the supplementary Immunization 
Activity and National Immunization Days in areas 
affected by outbreaks and areas affected by the 
outbreak successfully stopped the transmission of 
wild polio viruses. The last case was found in 2006. 
Cases are generally found in children living in the 
vicinity of rivers, areas with high population mobility, 
low immunization coverage, high population density, 
poor sanitation. Active and sensitive surveillance 
can cause cases to be found in certain areas and in 
large numbers. 7
Along with the AFP cases due to wild poliovirus, AFP 
cases due to type 1 VDPV were found in Madura, 
East Java in 2005. This finding was different from 
other countries in the world as  the type of poliovirus 
that mutates and becomes VDPV generally is type 2 
polio virus.5 One of the causes of emergence of VDPV 
is the low number of children who have immunity 
to poliovirus.7,25 Low immunization coverage was 
found in 64% of VDPV cases and 50% of cases have 
never been immunized against poliovirus. VDPV 
transmission had occurred before the 2005 VDPV 
outbreak and no cases could be found due to AFP 
surveillance being relatively less active in the area. 
Based on 2003 and 2004 data, it was found that AFP 
surveillance targets before 2005 in that area were still 
below the WHO recommended target. In addition to 
Non Polio AFP rates in that year were <1 / 100,000 
population (0.4 and 0.7) and adequate specimens 
were also below 80%. In addition, cold chains that 
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are not properly managed also cause the stability 
of the virus to be disrupted during delivery to the 
laboratory so that the virus were no longer viable and 
were not detected by laboratory test.7,23-26 Based on 
the specific results of poliovirus isolates in VDPV 
cases,  mutation nucleotide differences between 1.1-
1.2% found occurred for 2 years.
The vaccine poliovirus was also found in the stool 
from AFP cases. Indonesia is still using OPV (Oral 
Poliovirus) for routine vaccination. Vaccine poliovirus 
replicates in the human intestine and is excreted 
through stool. Outbreak Response Immunization 
(ORI) in outbreak area causes the poliovirus vaccine 
to be found in the stool of children who have just 
received immunization in the last 3 months.15-16. Data 
of AFP cases from 2003-2013 shows that vaccine 
poliovirus type 3 was the most frequently found 
even though some literatures showed that vaccine 
poliovirus type 2 was most frequently found because 
of its characteristics that longer circulated and 
transmitted.27-29 Based on Troy et al study in Mexico, 
shows that vaccine poliovirus type 3 found in 60% 
in children who recently received OPV. It showed 
that after direct vaccination, poliovirus type 3 most 
frequently detected in stool compared to vaccine 
poliovirus type 1 and 2.29 The vaccine poliovirus can 
turn into virulent in the human body and causes the 
same paralysis as wild poliovirus (vaccine asosiated 
poliovirus /VaPP). Further investigation is carried 
out to decide whether the vaccine virus that enters the 
child’s body changes its nature to become virulent 
and causes paralysis.29
In conclusion, good quality AFP surveillance 
helps government programmes in detecting the 
transmission of wild poliovirus and ensuring that 
wild poliovirus can be stopped transmitting through 
laboratory evidence. This evidence can be used as 
a document to achieve polio-free certification and 
program legacy in maintaining Indonesia free of wild 
poliovirus. Improved  sensitive AFP surveillance 
performance is needed to provide more quality 
evidence so that eradication of poliovirus can be 
achieved globally. 
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